The Immunogenetics of Smallpox Vaccination

Stanley Jr., Samuel L.; Frey,4, Sharon E.; Taillon-Miller, Patricia; Guo, Jianhua; Miller, Raymond D.; Koboldt, Daniel C.; Elashoff, Michael; Christensen, Ryan; Saccone, Nancy L.; Belshe, Robert B.
July 2007
Journal of Infectious Diseases;7/15/2007, Vol. 196 Issue 2, p212
Academic Journal
We hypothesized that individuals who develop fever after smallpox vaccination have genetically determined differences in their immune responses to vaccinia virus. We looked for an association between the development of fever and single-nucleotide polymorphisms (SNPs) in 19 candidate genes in 346 individuals previously assessed for clinical responses to smallpox vaccination. Fever after smallpox vaccination is associated with specific haplotypes in the interleukin (IL)-1 gene complex and in the IL18 gene. A haplotype in the IL4 gene was highly significant for reduced susceptibility to the development of fever after vaccination among vaccinianaive individuals. Our results indicate that certain haplotypes in the IL-1 gene complex and in IL18 and IL4 predict an altered likelihood of the development of fever after smallpox vaccination. Our findings also raise the possibility that these same haplotypes may identify individuals at risk for the development of fever after receipt of other live virus vaccines, providing information that could be useful in anticipating and preventing more-serious adverse events.


Related Articles

  • Genetic Basis for Adverse Events after Smallpox Vaccination. Reif, David M.; McKinney, Brett A.; Motsinger, Alison A.; Chanock, Stephen J.; Edwards, Kathryn M.; Rock, Michael T.; Moore, Jason H.; Crowe Jr., James E. // Journal of Infectious Diseases;7/1/2008, Vol. 198 Issue 1, p16 

    Identifying genetic factors associated with the development of adverse events might allow screening before vaccinia virus administration. Two independent clinical trials of the smallpox vaccine (Aventis Pasteur) were conducted in healthy, vaccinia virus-naive adult volunteers. Volunteers were...

  • Should you volunteer for the smallpox vaccine? Lorenzo, Penny // RN;Apr2003, Vol. 66 Issue 4, p69 

    Focuses on nurses' need for smallpox vaccine. Benefits and risks from smallpox vaccine; Coverage of lost time and wages.

  • Smallpox vaccine plan mired in concern over risks vs. benefits. Hitchens, Kathy // Drug Topics;2/17/2003, Vol. 147 Issue 4, p20 

    Reports issues concerning the risks and benefits of smallpox vaccination plan in the U.S. Shipment of the vaccine; Risks of adverse effects that can affect the effectiveness of live virus vaccine; Details on the liability protection given to individuals involved in the vaccination process.

  • Status of nation's smallpox vaccine reserve improves.  // American Journal of Health-System Pharmacy;5/1/2002, Vol. 59 Issue 9, p822 

    Discusses factors that contributed to the improvement in the potential national supply of smallpox vaccine in the U.S., as of March 2002. Evidence given by an online report by editors of the periodical 'New England Journal of Medicine' on the potency of vaccine stocks; Report on a previously...

  • Reply to Friedman. Kennedy, Jeffrey S.; Gurwith, Marc; Yokote, Hiroyuki; Greenberg, Richard N. // Journal of Infectious Diseases;Oct2012, Vol. 206 Issue 7, p1149 

    A letter to the editor is presented in response to a letter to the editor about the next generation of smallpox vaccines and poxviruses used as vectors in a 2012 issue.

  • Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Kennedy, Richard; Ovsyannikova, Inna; Shane Pankratz, V.; Haralambieva, Iana; Vierkant, Robert; Poland, Gregory // Human Genetics;Sep2012, Vol. 131 Issue 9, p1403 

    The role that genetics play in response to infection or disease is becoming increasingly clear as we learn more about immunogenetics and host-pathogen interactions. Here we report a genome-wide analysis of the effects of host genetic variation on cytokine responses to vaccinia virus stimulation...

  • Generalised vaccinia: case report.  // Reactions Weekly;5/29/2004, Issue 1003, p13 

    Discusses research being done on a woman who developed generalized vaccinia after receiving smallpox vaccine. Reference to a study by C. D. Kelly et al, published in the March 2004 issue of the "Journal of Clinical Microbiology"; Diseases developed after the patient have udergone smallpox...

  • Eradication of Smallpox.  // British Medical Journal;5/3/1975, Vol. 2 Issue 5965, p237 

    Focuses on the decreasing incidence of smallpox. Availability of freeze-dried vaccine in 1962; Organization of an eradication campaign by the World Health Organization in 1967; Presentation on the success of the campaign at a symposium at the Royal Society of Tropical Medicine and Hygiene in...

  • Smallpox vaccine: vaccinia DNA transmission risk?  // Reactions Weekly;5/6/2006, Issue 1100, p5 

    Provides information on research regarding smallpox vaccination. Percentage of patients who were vaccine-naive with a vaccinia strain; Conclusion drawn by the researchers with regards to vaccinia DNA transmission risk.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics